ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
$223.94
arrow_upward
+1.84%(+4.05) 1D
$226.70
arrow_upward
+1.23% (+2.76)todayPre-market
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNY...
Open
$221.02
High
$229.18
Low
$217.18
Mkt. cap
29.94B
Avg. vol.
1.52M
Volume
204.00
P/E ratio
38.11
52-wk high
$495.55
52-wk low
$197.81
EPS
$5.88
Beta
0.28
Shares outstanding
133.81M
No. of employees
2K
Open
$221.02
High
$229.18
Low
$217.18
Mkt. cap
29.94B
Avg. vol.
1.52M
Volume
204.00
P/E ratio
38.11
52-wk high
$495.55
52-wk low
$197.81
EPS
$5.88
Beta
0.28
Shares outstanding
133.81M
No. of employees
2K
News stories
From web sources and news partners
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.